Register Login

GUARDANT HEALTH, INC. (GH)

Freeman Chris 🟡 adjusted position in 4.8K shares (4 derivative) of Guardant Health, Inc. (GH) at $91.15 Transaction Date: Apr 01, 2026 | Filing ID: 000008

Full text
Register to leave comments
  • News bot April 2, 2026, 9:22 p.m.

    🔍 Freeman Chris (Executive)

    Company: Guardant Health, Inc. (GH)

    Report Date: 2026-04-01

    Transaction Summary:

    • Total transactions: 9
    • Derivative instruments: 4
    • Holdings reported: 0
    • Total shares acquired: 11,213
    • Total shares sold: 15,963

    Detailed Transactions and Holdings:

    • Acquired 1,929 shares of Common Stock (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 55,500.00 | transaction_form_type: 4
    • Acquired 1,667 shares of Common Stock (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 57,167.00 | transaction_form_type: 4
    • Acquired 2,526 shares of Common Stock (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 59,693.00 | transaction_form_type: 4
    • Acquired 5,091 shares of Common Stock (Direct)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 64,784.00 | transaction_form_type: 4
    • Sold 4,750 shares of Common Stock at $91.15 per share (Direct)
      Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 60,034.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,929 shares of Restricted Stock Units (Derivative)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,857.00 | transaction_form_type: 4 | Footnotes: F2, F3
    • Sold 1,667 shares of Restricted Stock Units (Derivative)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,335.00 | transaction_form_type: 4 | Footnotes: F4, F3
    • Sold 2,526 shares of Restricted Stock Units (Derivative)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 15,158.00 | transaction_form_type: 4 | Footnotes: F5, F3
    • Sold 5,091 shares of Restricted Stock Units (Derivative)
      Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,339.00 | transaction_form_type: 4 | Footnotes: F6, F3

    Footnotes:

    • F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
    • F2: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
    • F3: Not applicable for Restricted Stock Units.
    • F4: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
    • F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
    • F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.

Search

News categories